Phase 1 Low Risk Myelodysplastic Syndromes Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

Rigel Pharmaceuticals86 enrolled15 locationsNCT05308264

Recruiting

Phase 1

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

Low Risk Myelodysplastic Syndromes

Groupe Francophone des Myelodysplasies24 enrolled3 locationsNCT06670222